AFAP-110 is a binding partner for Src and PKCc_ and affects changes in actin filament integrity as an actin filament cross linking protein and as a cSrc activating protein. Our data support the hypothesis that AFAP-110 relays signals from PKCc_ that promote (i) actin filament cross linking and (ii) activation of cSrc. These two functions are relevant to cell motility as actin filament cross linking is required at the leading edge of a cell to provide protrusive force for extension of lamellipodia, while cSrc activation directs a loss of actin filament integrity across the cell body and stimulates downstream signals that promote motility and invasion. The intrinsic ability of AFAP-110 to cross link actin filaments and activate cSrc is revealed in response to PKCc_ signaling. AFAP-110 is a binding partner and substrate for PKCc_, in vivo and in vitro. Interactions with PKCc_ affect a conformational change upon AFAP-110 that promotes its ability to cross link actin filaments. PKCa activation also directs AFAP-110 to move to and activate cSrc through SH3 binding. Activated forms of AFAP-110 can independently activate cSrc and promote cell motility and invasion. Dominant-negative AFAP-110 will block PKCcx-directed cSrc activation and changes in actin filament integrity. This project will determine the mechanism by which AFAP-110 relays signals from PKCc_ that regulate (i) actin filament cross linking, (ii) cSrc activation and (iii) cell motility and invasion. The significance of this work is that (a) cSrc activation correlates with acquisition of the invasive phenotype in human tumors, (b) AFAP-110 can activate cSrc and affect both cellular motility and invasion and (c) PKC_x, cSrc and AFAP-110 are upregulated in breast cancer tissues and cell lines that are invasive. Thus, AFAP- 110 may be a novel biomarker or target for intervention in invasive cancers where PKCoc and cSrc are activated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA060731-13S1
Application #
7333090
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Ogunbiyi, Peter
Project Start
1994-05-01
Project End
2009-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
13
Fiscal Year
2007
Total Cost
$38,296
Indirect Cost
Name
West Virginia University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Cunnick, J M; Kim, S; Hadsell, J et al. (2015) Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland. Oncogene 34:2640-9
Snyder, Brandi N; Cho, YoungJin; Qian, Yong et al. (2011) AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes. Eur J Cell Biol 90:376-89
Clump, David A; Yu, Jing Jie; Cho, Youngjin et al. (2010) A Polymorphic Variant of AFAP-110 Enhances cSrc Activity. Transl Oncol 3:276-85
Xu, Xiaohua; Harder, Jennifer; Flynn, Daniel C et al. (2009) AFAP120 regulates actin organization during neuronal differentiation. Differentiation 77:38-47
Guo, Nancy L; Wan, Ying-Wooi; Tosun, Kursad et al. (2008) Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res 14:8213-20